Simple Summary
Melanoma is an aggressive skin tumour accounting for significant mortality. The gold standard for diagnosis remains clinical examination followed by surgical excision and histopathological evaluation, while metastasis detection primarily relies on cross-sectional imaging. However, recent advances in ultrasound technology—such as high-frequency ultrasound, microvascular flow imaging, and contrast-enhanced ultrasound—can provide promising preoperative information for disease management that is complementary to invasive techniques. In addition, ultrasound has therapeutic significance as a minimally invasive procedure, particularly for localised primary or relapsing melanoma. While several published studies have discussed the role of ultrasound from specific perspectives in melanoma management, this review aims to summarise the most relevant diagnostic and therapeutic applications of ultrasound in melanoma care centred around the technique itself.
Abstract
Cutaneous melanoma is an aggressive skin tumour that accounts for significant mortality. Diagnosis relies on clinical examination and histopathological work-up after surgical removal. Tumour thickness (Breslow depth), determined by the pathologist, is crucial for staging and treatment. Cross-sectional imaging is mainly used to detect metastases, while sonography serves to identify pathologic lymph nodes and guide interventions. However, advances in ultrasound technology provide promising non-invasive evaluation of primary tumours that complements conventional methods. Our aim is to briefly review the currently available ultrasound-based techniques for diagnosing and managing cutaneous melanoma. High-frequency ultrasound can precisely evaluate tumour depth, competing with histopathological measurement. Doppler techniques and elastography, by mapping vascularity and tissue stiffness, provide additional clues to differentiate benign and malignant lesions. Contrast-enhanced ultrasound is not only a valuable tool for characterising the primary tumour and searching for relapse/metastasis, but it is also applied in targeted therapies. New wave ultrasound-based treatment options like sonoporation, sonodynamic therapy, and high-intensity focused ultrasound show promising preclinical results. Adopting artificial intelligence into melanoma care may reduce variability and increase diagnostic and therapeutic accuracy, though clinical validation remains limited.